LOWELL, Mass., Oct. 11, 2016 -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the addition of Ed Ognibene as Vice President of Product Development. Ed will report directly to the CEO, Robert Spignesi.
Mr. Ognibene brings over 20 years of technology and product development experience with sophisticated scientific instrumentation. Most recently, he held the position of Director of Engineering / Systems Development at Waters Corporation in the Separation Systems division, where he successfully managed the R&D and Engineering teams from the acquisition of Thar Instruments, Inc., as well as the integration of these groups into the broader corporate development organization. Concurrently, Mr. Ognibene oversaw a major development program to replace a product line with innovative new systems. Prior to this, he was responsible for driving the development of novel industry leading chromatographic platform systems. Before Waters, Mr. Ognibene worked at SatCon Technologies, a MIT start-up, where he managed the Mechanical Engineering Group and was also responsible for Program Management and technology/business development.
“I am thrilled to welcome an executive of Ed’s caliber and experience to our team,” said CEO Robert Spignesi. “His track record of leading innovative technology, product development programs, and organizations will be instrumental to our continued growth and success.”
“I am pleased to step into the VP of Product Development role and take on this assignment during an exciting phase of the company’s growth,” said Mr. Ognibene. “I look forward to ensuring that our customers experience the most innovative products as they implement Rapid Micro Biosystems’ technologies throughout their organizations.”
Ed holds a PhD and MS in Mechanical Engineering from MIT and a BSME from SUNY Stony Brook. Ed is a member of ASME, Tau Beta Pi, and Sigma Xi honor societies.
About Rapid Micro Biosystems
Rapid Micro Biosystems delivers the Growth Direct™ System, an automated, non-destructive rapid detection and enumeration technology based on the compendial method for microbial quality control in pharmaceutical manufacturing. The system automates and accelerates detection and enumeration in the areas of sterility testing, environmental monitoring, and bioburden testing, eliminating manual steps and analysis. The detection technology uses the natural auto-fluorescence of microbes and requires no reagents. For more information about Rapid Micro Biosystems visit www.rapidmicrobio.com
Contact: Eugenia Kendrick Rapid Micro Biosystems [email protected]


Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Britain Courts Anthropic Amid US Defense Department Dispute
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 



